Edition:
India

Tasly Pharmaceutical Group Co Ltd (600535.SS)

600535.SS on Shanghai Stock Exchange

16.69CNY
19 Jul 2019
Change (% chg)

¥0.07 (+0.42%)
Prev Close
¥16.62
Open
¥16.62
Day's High
¥16.83
Day's Low
¥16.58
Volume
8,151,626
Avg. Vol
13,746,074
52-wk High
¥26.66
52-wk Low
¥15.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 4,571.37 0.296
FY 2018 Dec '18 4,964.88 0.116
Sep '18 4,548.71 0.294
Jun '18 4,523.60 0.366
Mar '18 3,952.35 0.246
FY 2017 Dec '17 4,932.35 0.157
Sep '17 3,897.33 0.253
Jun '17 3,916.81 0.290
Mar '17 3,347.66 0.210
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 1 5,126.35 5,126.35 5,126.35 5,253.14
Quarter Ending Dec-19 1 5,126.35 5,126.35 5,126.35 5,253.14
Year Ending Dec-19 10 20,438.80 21,200.80 19,950.40 20,699.10
Year Ending Dec-20 10 22,977.80 24,109.40 21,823.00 23,656.20
Earnings (per share)
Quarter Ending Sep-19 2 0.35 0.42 0.27 0.38
Quarter Ending Dec-19 2 0.28 0.28 0.27 0.41
Year Ending Dec-19 11 1.17 1.35 1.06 1.22
Year Ending Dec-20 11 1.35 1.63 1.16 1.47
LT Growth Rate (%) 1 17.18 17.18 17.18 --
Sales and Profit Figures in China Yuan Renminbi (CNY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 15.57 30.63 34.52
P/E High - Last 5 Yrs. 38.11 47.56 54.21
P/E Low - Last 5 Yrs. 18.80 27.40 28.29
Beta 0.68 1.00 0.99
Price to Sales (TTM) 1.36 6.17 7.97
Price to Book (MRQ) 2.29 3.94 4.45
Price to Tangible Book (MRQ) 2.73 4.25 5.18
Price to Cash Flow (TTM) -- 22.45 24.33
% Owned Institutions -- 0.77 1.75

Dividends

  Company industry sector
Dividend Yield 1.80 1.78 1.63
Dividend Yield - 5 Year Avg 1.18 1.48 1.37
Dividend 5 Year Growth Rate 3.71 6.75 6.83
Payout Ratio(TTM) 33.27 51.44 47.44

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 15.66 12.77 14.69
Sales (TTM) vs TTM 1 Yr. Ago 11.44 6.32 8.20
Sales - 5 Yr. Growth Rate 10.12 8.37 9.46
EPS (MRQ) vs Qtr. 1 Yr. Ago 20.64 16.93 18.14
EPS (TTM) vs TTM 1 Yr. Ago 13.42 -- --
EPS - 5 Yr. Growth Rate 6.11 5.65 7.10
Capital Spending - 5 Yr. Growth Rate -0.75 6.92 7.89

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.90 2.54 2.54
Current Ratio (MRQ) 2.21 3.58 3.54
LT Debt to Equity (MRQ) 43.80 11.58 12.58
Total Debt to Equity (MRQ) 78.19 16.07 17.60
Interest Coverage (TTM) 5.84 7.58 14.89

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 35.10 51.26 50.19
Gross Margin - 5 Yr. Avg. 36.95 50.50 51.31
EBITD Margin (TTM) 13.94 -- --
EBITD - 5 Yr. Avg 16.01 17.60 16.45
Operating Margin (TTM) 10.94 -2.00 -6.60
Operating Margin - 5 Yr. Avg. 11.66 13.93 11.94
Pre-Tax Margin (TTM) 11.02 -2.33 -6.95
Pre-Tax Margin - 5 Yr. Avg. 11.81 18.81 15.91
Net Profit Margin (TTM) 8.96 -6.01 -10.73
Net Profit Margin - 5 Yr. Avg. 9.73 14.13 11.28
Effective Tax Rate (TTM) 18.63 20.21 20.55
Effective Tax Rate - 5 Yr. Avg. 17.55 22.94 24.50

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,006,530 1,019,456,199 879,617,670
Net Income/Employee (TTM) 179,866 119,302,590 102,957,990
Receivable Turnover (TTM) 2.17 5.64 5.90
Inventory Turnover (TTM) 4.94 2.60 3.64
Asset Turnover (TTM) 0.79 0.89 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 7.05 10.55 10.25
Return on Assets - 5 Yr. Avg. 8.48 11.72 11.20
Return on Investment (TTM) 11.86 13.02 12.69
Return on Investment - 5 Yr. Avg. 16.50 14.83 14.18
Return on Equity (TTM) 16.19 14.18 17.17
Return on Equity - 5 Yr. Avg. 19.22 15.93 15.55
  1 Year 3 Year 5 Year
Sales % 11.78 10.79 10.12
EPS (TTM) % 12.25 1.48 6.11
Dividend % 5.00 0.00 3.71
Note: Units in Millions of US Dollars

Performance for Tasly Pharmaceutical Group Co Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.69%
# of Holders: 119
Total Shares Held: 161,746,869
3 Mo. Net Change: -1,622,527
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 23
# Reduced Positions: 21
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.